# Rhaponticin **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/rhaponticin **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-29 **Evidence Score:** 2 / 10 **Category:** Compound **Also Known As:** Rhaponticin glucoside, 3,3',5-trihydroxy-4'-methoxystilbene 3-O-β-D-glucoside, Rheum stilbene glucoside, Rhaponticum stilbenoid, Chinese rhubarb stilbene, Desoxyrhapontigenin 3-O-glucoside ## Overview Rhaponticin is a stilbene glycoside found primarily in rhubarb root (Rheum rhaponticum) that acts as a phytoestrogen by binding to estrogen receptors alpha and beta. Its primary mechanisms involve modulation of estrogenic signaling pathways and [antioxidant activity](/ingredients/condition/antioxidant), placing it in research for [bone health](/ingredients/condition/bone-health), [cardiovascular](/ingredients/condition/heart-health) support, and [hormonal balance](/ingredients/condition/hormonal). ## Health Benefits • Potential support for [bone health](/ingredients/condition/bone-health), as indicated in experimental models, though specific human data are limited [3]. • May influence [blood pressure regulation](/ingredients/condition/heart-health) based on preliminary studies [3]. • Rhaponticin is suggested to act similarly to estrogens, potentially supporting [hormonal balance](/ingredients/condition/hormonal), though detailed mechanisms are not provided [4]. • Contains [antioxidant](/ingredients/condition/antioxidant) properties due to its classification as a hydroxystilbene [1]. • Found in standardized preparations like ERr 731, which have demonstrated safety and efficacy in clinical observations [4]. ## Mechanism of Action Rhaponticin binds to estrogen receptors ERα and ERβ, mimicking endogenous estrogens like estradiol and modulating downstream gene transcription involved in bone remodeling and [vascular tone](/ingredients/condition/heart-health). It is metabolized by intestinal microbiota into rhapontigenin, the aglycone form, which exhibits stronger receptor affinity and bioavailability. Additionally, rhaponticin scavenges [reactive oxygen species](/ingredients/condition/antioxidant) (ROS) and may inhibit NF-κB signaling, contributing to its observed [anti-inflammatory](/ingredients/condition/inflammation) and cardioprotective effects. ## Clinical Summary Most evidence for rhaponticin comes from in vitro cell studies and rodent models rather than human clinical trials, limiting the strength of current conclusions. Animal studies have demonstrated reductions in systolic [blood pressure](/ingredients/condition/heart-health) and improvements in [bone mineral density](/ingredients/condition/bone-health) markers, though specific effect sizes vary across models. A small number of human studies on rhubarb-derived extracts (which include rhaponticin alongside other stilbenes) suggest modest benefits for menopausal symptom relief, but isolating rhaponticin's individual contribution remains methodologically challenging. Robust, large-scale randomized controlled trials in humans are currently lacking, and all proposed benefits must be considered preliminary. ## Nutritional Profile Rhaponticin (also known as Rhapontin or 3,5-dimethoxy-4'-hydroxystilbene-3'-O-β-D-glucoside) is a stilbene glycoside compound, not a whole food, and therefore does not contain conventional macronutrients, micronutrients, or dietary fiber in the traditional sense. Molecular weight: approximately 420.44 g/mol. It is the glucoside form of rhapontigenin (its aglycone), connected via a β-D-glucopyranoside linkage. Bioactive compound classification: hydroxystilbene glycoside, structurally analogous to resveratrol-class polyphenols. Typical concentrations in source plants (e.g., Rheum rhaponticum, rhubarb root): approximately 0.1–2% dry weight depending on plant part and extraction method. Bioavailability: oral bioavailability is moderate; intestinal and hepatic [metabolism](/ingredients/condition/weight-management) converts rhaponticin to its active aglycone rhapontigenin via glycosidic bond cleavage by gut microbiota β-glucosidases, which is considered the primary bioactive form in systemic circulation. Peak plasma concentration of rhapontigenin typically observed within 1–3 hours post-ingestion in animal models. Lipophilicity (logP estimated ~2.5 for aglycone) suggests moderate membrane permeability. No significant caloric, protein, fat, or carbohydrate content is attributed to this isolated compound in pharmacological use. ## Dosage & Preparation The research does not specify clinically studied dosage ranges for rhaponticin. Standardized extracts such as ERr 731 exist but lack detailed dosage recommendations in the available sources. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Rhaponticin is generally regarded as low-toxicity at typical dietary exposure levels, but high-dose supplementation has not been rigorously evaluated for long-term safety in humans. Due to its phytoestrogenic activity, it may interact with hormone-sensitive medications, including estrogen therapies, tamoxifen, and aromatase inhibitors, potentially altering their efficacy. Individuals with hormone-sensitive conditions such as estrogen receptor-positive breast cancer, uterine fibroids, or endometriosis should avoid supplementation without medical supervision. Pregnant and breastfeeding women should not use rhaponticin supplements, as estrogenic compounds may interfere with fetal hormonal development. ## Scientific Research The clinical evidence for rhaponticin is limited, with some studies identifying it as a major component of Rheum officinale extracts affecting [bone health](/ingredients/condition/bone-health) and [blood pressure](/ingredients/condition/heart-health) [3]. Specific human clinical trial data, including PMIDs, are not detailed in the research results. ## Historical & Cultural Context While *Rheum officinale* is recognized as a Chinese medicinal herb, the research does not detail rhaponticin's specific traditional applications or historical use. Its role in traditional medicine remains undocumented in the provided sources. ## Synergistic Combinations Resveratrol, Quercetin, Curcumin, Green tea extract, Pterostilbene ## Frequently Asked Questions ### What is rhaponticin and what plant does it come from? Rhaponticin is a stilbene glycoside naturally occurring in the roots and rhizomes of Rheum rhaponticum (rhubarb) and related Rheum species. It belongs to the same chemical class as resveratrol and is structurally distinguished by a glucose moiety attached to its stilbene backbone, which is cleaved by gut bacteria to produce the more bioactive aglycone rhapontigenin. ### Does rhaponticin act like estrogen in the body? Yes, rhaponticin and its metabolite rhapontigenin bind to both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ), qualifying it as a phytoestrogen. This binding activates estrogen-responsive genes involved in bone turnover, vascular function, and cell proliferation, though its binding affinity is considerably weaker than endogenous 17β-estradiol. This partial agonism may offer hormonal support with a potentially reduced risk profile compared to synthetic estrogens, though human data confirming this are insufficient. ### Can rhaponticin support bone health? Preclinical studies in ovariectomized rodent models—which simulate postmenopausal bone loss—show that rhaponticin supplementation can attenuate reductions in bone mineral density, likely through estrogenic upregulation of osteoblast activity and suppression of osteoclast differentiation via RANKL/OPG signaling. However, no human clinical trials have specifically tested rhaponticin for osteoporosis or bone density outcomes, so these findings cannot yet be directly translated to clinical recommendations. ### What is the difference between rhaponticin and rhapontigenin? Rhaponticin is the glycoside form, meaning it carries a glucose sugar attached to the stilbene core, whereas rhapontigenin is the aglycone form produced when gut microbiota cleave that glucose bond. Rhapontigenin demonstrates higher lipophilicity and greater binding affinity to estrogen receptors compared to rhaponticin, making it the more pharmacologically active compound in circulation. The conversion efficiency from rhaponticin to rhapontigenin varies between individuals depending on gut microbiome composition. ### Are there any drug interactions with rhaponticin supplements? Rhaponticin's phytoestrogenic activity creates a clinically relevant interaction risk with hormone-modulating drugs, including selective estrogen receptor modulators (SERMs) like tamoxifen and raloxifene, as well as exogenous estrogen therapies and aromatase inhibitors used in breast cancer treatment. It may also potentially interact with anticoagulants like warfarin, given that stilbene compounds can influence CYP450 enzyme activity, specifically CYP2C9 and CYP3A4, though direct pharmacokinetic studies on rhaponticin are limited. Patients on any hormonal or anticoagulant therapy should consult a physician before use. ### What is the current state of clinical research evidence for rhaponticin in humans? Most research on rhaponticin has been conducted in experimental and animal models, with limited human clinical trials to date. While promising results have been observed for bone health and blood pressure regulation in preliminary studies, stronger and more extensive human data are needed to establish definitive efficacy and optimal dosing. The gap between laboratory findings and human outcomes means consumers should view rhaponticin supplements as investigational rather than proven interventions. ### What are the natural food sources of rhaponticin? Rhaponticin is primarily found in Rheum species, particularly Rheum rhaponticum (Siberian rhubarb) and related plants in the Polygonaceae family. While rhubarb root is the most concentrated natural source, the amount of rhaponticin in typical dietary portions of rhubarb may be insufficient to match therapeutic doses used in supplement studies. For this reason, concentrated extracts or supplements are generally used to achieve the levels tested in research. ### Who is most likely to benefit from rhaponticin supplementation based on current evidence? Individuals interested in bone health support and those approaching or experiencing hormonal transitions may find rhaponticin of interest, though evidence is preliminary. People with blood pressure concerns may also consider it based on early research, though consultation with a healthcare provider is essential before use. Since clinical human data remain limited, rhaponticin is best suited for those willing to use an investigational supplement under professional guidance rather than as a first-line treatment. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*